FAQs Patent Questions

Question:What is the difference between patents and exclusivity?

Answer:
Patents and exclusivity work in a similar fashion but are distinctly different from one another. Patents are granted by the patent and trademark office anywhere along the development lifeline of a drug and can encompass a wide range of claims. Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

Question:How do I access sequences for a particular document?

Answer:
In order to access the sequence information for a patent or published application, you may submit the document number via the PSIPS home page. The PSIPS document detail page will then show you the number of sequences (SEQ ID NOs.) within the selected Sequence Listing. You will have the opportunity to view one or more sequences, or download the entire Sequence Listing.

Question:How is PSIPS generally to be used?

Answer:
At present, this system acts as a storage and retrieval site for Sequence Listings that are at least 300 pages (roughly 600Kb), mega table sections that are at least 200 contiguous pages, and other mega items. The data have been included in either a granted US patent or a published US patent application. Shorter Sequence Listings and tables are accessible via Patents-, and Applications-, on-the-Web home pages.

Bookmark:           
Permalink:  http://S-0.ORG/tkqtZ5v

Contact our Patent Professionals to ensure you complete the patent filing process correctly or for violation of your patent rights.